ICUI
Price
$134.96
Change
+$4.91 (+3.78%)
Updated
Mar 11, 02:28 PM (EDT)
Capitalization
2.55B
62 days until earnings call
VCYT
Price
$31.99
Change
+$1.61 (+5.30%)
Updated
Mar 11, 03:40 PM (EDT)
Capitalization
1.66B
63 days until earnings call
Ad is loading...

ICUI vs VCYT

Header iconICUI vs VCYT Comparison
Open Charts ICUI vs VCYTBanner chart's image
ICU Medical
Price$134.96
Change+$4.91 (+3.78%)
Volume$200
Capitalization2.55B
Veracyte
Price$31.99
Change+$1.61 (+5.30%)
Volume$2.2K
Capitalization1.66B
ICUI vs VCYT Comparison Chart
Loading...
ICUI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ICUI vs. VCYT commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ICUI is a Buy and VCYT is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Mar 11, 2025
Stock price -- (ICUI: $130.05 vs. VCYT: $30.39)
Brand notoriety: ICUI and VCYT are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ICUI: 232% vs. VCYT: 143%
Market capitalization -- ICUI: $2.55B vs. VCYT: $1.66B
ICUI [@Medical Specialties] is valued at $2.55B. VCYT’s [@Medical Specialties] market capitalization is $1.66B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ICUI’s FA Score shows that 1 FA rating(s) are green whileVCYT’s FA Score has 0 green FA rating(s).

  • ICUI’s FA Score: 1 green, 4 red.
  • VCYT’s FA Score: 0 green, 5 red.
According to our system of comparison, ICUI is a better buy in the long-term than VCYT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ICUI’s TA Score shows that 4 TA indicator(s) are bullish while VCYT’s TA Score has 3 bullish TA indicator(s).

  • ICUI’s TA Score: 4 bullish, 6 bearish.
  • VCYT’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ICUI is a better buy in the short-term than VCYT.

Price Growth

ICUI (@Medical Specialties) experienced а -8.13% price change this week, while VCYT (@Medical Specialties) price change was -9.45% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.98%. For the same industry, the average monthly price growth was -7.91%, and the average quarterly price growth was -4.50%.

Reported Earning Dates

ICUI is expected to report earnings on May 12, 2025.

VCYT is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Medical Specialties (-1.98% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ICUI($2.55B) has a higher market cap than VCYT($1.66B). ICUI YTD gains are higher at: -16.189 vs. VCYT (-23.258). ICUI has higher annual earnings (EBITDA): 253M vs. VCYT (-49.41M). ICUI has more cash in the bank: 255M vs. VCYT (216M). VCYT has less debt than ICUI: VCYT (12.6M) vs ICUI (1.7B). ICUI has higher revenues than VCYT: ICUI (2.26B) vs VCYT (361M).
ICUIVCYTICUI / VCYT
Capitalization2.55B1.66B153%
EBITDA253M-49.41M-512%
Gain YTD-16.189-23.25870%
P/E Ratio333.33N/A-
Revenue2.26B361M626%
Total Cash255M216M118%
Total Debt1.7B12.6M13,524%
FUNDAMENTALS RATINGS
ICUI vs VCYT: Fundamental Ratings
ICUI
VCYT
OUTLOOK RATING
1..100
5554
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
81
Overvalued
PROFIT vs RISK RATING
1..100
10090
SMR RATING
1..100
8786
PRICE GROWTH RATING
1..100
9692
P/E GROWTH RATING
1..100
257
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VCYT's Valuation (81) in the Biotechnology industry is in the same range as ICUI (92) in the Medical Specialties industry. This means that VCYT’s stock grew similarly to ICUI’s over the last 12 months.

VCYT's Profit vs Risk Rating (90) in the Biotechnology industry is in the same range as ICUI (100) in the Medical Specialties industry. This means that VCYT’s stock grew similarly to ICUI’s over the last 12 months.

VCYT's SMR Rating (86) in the Biotechnology industry is in the same range as ICUI (87) in the Medical Specialties industry. This means that VCYT’s stock grew similarly to ICUI’s over the last 12 months.

VCYT's Price Growth Rating (92) in the Biotechnology industry is in the same range as ICUI (96) in the Medical Specialties industry. This means that VCYT’s stock grew similarly to ICUI’s over the last 12 months.

ICUI's P/E Growth Rating (2) in the Medical Specialties industry is somewhat better than the same rating for VCYT (57) in the Biotechnology industry. This means that ICUI’s stock grew somewhat faster than VCYT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ICUIVCYT
RSI
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
66%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
64%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 21 days ago
69%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
ICUI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MRFGX22.74N/A
N/A
BlackRock Capital Appreciation R
MBLDX12.06N/A
N/A
MassMutual Balanced R5
DBMYX27.76N/A
N/A
BNY Mellon Sm/Md Cp Gr Y
OBIIX9.48N/A
N/A
Oberweis International Opps Instl
JLGQX75.83N/A
N/A
JPMorgan Large Cap Growth R4

ICUI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ICUI has been loosely correlated with CLPT. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ICUI jumps, then CLPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ICUI
1D Price
Change %
ICUI100%
-8.40%
CLPT - ICUI
48%
Loosely correlated
-6.35%
NVST - ICUI
43%
Loosely correlated
-4.99%
HBIO - ICUI
42%
Loosely correlated
-5.12%
VMD - ICUI
42%
Loosely correlated
-1.33%
GKOS - ICUI
41%
Loosely correlated
-7.22%
More

VCYT and

Correlation & Price change

A.I.dvisor indicates that over the last year, VCYT has been closely correlated with NTLA. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if VCYT jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VCYT
1D Price
Change %
VCYT100%
-5.09%
NTLA - VCYT
69%
Closely correlated
-8.60%
VCEL - VCYT
60%
Loosely correlated
-1.41%
AXON - VCYT
58%
Loosely correlated
-2.08%
DNA - VCYT
57%
Loosely correlated
-7.82%
ABCL - VCYT
55%
Loosely correlated
-5.36%
More